Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Sep 19, 2019

Oxford Nanopore Licenses CRISPR-Cas9 IP From Caribou Biosciences for Targeted Nanopore Sequencing

The firm said CRISPR will enable targeted sequencing of long regions of interest that were previously only accessible with long-read whole-genome sequencing.

Sep 11, 2019

Oxford Nanopore Responds in Court to Pacific Biosciences Allegations of Willful Infringement

The UK-based sequencing technology firm continues to seek invalidation of PacBio's patents, despite unsuccessful earlier efforts.

Sep 03, 2019

Denmark's Samplix Plans Commercial Expansion to Support Rollout of Xdrop System

Premium

The company believes that Xdrop will find adopters in academia and clinical research, although diagnostics is on its radar.

Jul 18, 2019

European Patent Office Revokes Second Pacific Biosciences Patent

The patent, EP3170904, "Compositions and methods for nucleic acid sequencing," is the second PacBio patent revoked by the EPO this year. 

Jul 08, 2019

Oxford Nanopore 2018 Revenues More Than Double; Firm Opens New Production Facility

In a message posted on Twitter today, Oxford Nanopore said that revenues grew to $43.7 million last year, up from $17.8 million in 2017.

May 24, 2019

Oxford Nanopore Previews Upcoming Products, Outlines Nanopore-Based DNA Data Storage Tech

Premium

At the company's annual user meeting in London, staff members previewed upgrades and changes that will result in higher throughput and accuracy at lower sequencing costs.

Apr 29, 2019

GrandOmics, Oxford Nanopore Partner on 100K Human Genomes Structural Variation Project

The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.

Apr 19, 2019

Oxford Nanopore Sequencing Shows Promise for Diagnosing Prosthetic Joint Infections

Premium

The method, presented at the European Congress of Clinical Microbiology and Infectious Diseases, may provide results in hours rather than a week or more.

Apr 16, 2019

Consortium Catalogs Structural Variation in Human Genomes Using Combination of Tools

The study used a variety of sequencing and mapping technologies, including from Illumina, Pacific Biosciences, 10X Genomics, Bionano Genomics, and Oxford Nanopore.

Mar 26, 2019

New Human Genome Reference Projects Combine Long Nanopore Reads, Other Data Types

Premium

The Telomere-to-Telomere consortium has already generated a gapless assembly of the human X chromosome and aims to complete all chromosomes over the next two years or so.

Pages

The Scan

Making a Mark

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Optimistic, Though Cautious

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

And Maybe a Fee

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

Nature Highlights Study Finding Differences in Infant Gut Microbiome by Delivery Mode, More

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.

What's Popular?

In Oxford Nanopore

  1. Oxford Nanopore Licenses CRISPR-Cas9 IP From Caribou Biosciences for Targeted Nanopore Sequencing

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.